vs
Side-by-side financial comparison of MOBIX LABS, INC (MOBX) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
MOBIX LABS, INC is the larger business by last-quarter revenue ($1.9M vs $1.4M, roughly 1.4× PLUS THERAPEUTICS, INC.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -540.0%, a 122.1% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -40.8%). Over the past eight quarters, MOBIX LABS, INC's revenue compounded faster (28.0% CAGR vs -9.7%).
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
MOBX vs PSTV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $1.4M |
| Net Profit | $-10.1M | $-5.7M |
| Gross Margin | 31.0% | — |
| Operating Margin | -471.1% | -420.0% |
| Net Margin | -540.0% | -417.9% |
| Revenue YoY | -40.8% | -3.2% |
| Net Profit YoY | 49.0% | -46.4% |
| EPS (diluted) | $-0.16 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9M | $1.4M | ||
| Q3 25 | $1.9M | $1.4M | ||
| Q2 25 | $2.4M | $1.4M | ||
| Q1 25 | $2.5M | $1.1M | ||
| Q4 24 | $3.2M | $1.4M | ||
| Q3 24 | $3.0M | $1.5M | ||
| Q2 24 | $2.1M | $1.3M | ||
| Q1 24 | $1.1M | $1.7M |
| Q4 25 | $-10.1M | $-5.7M | ||
| Q3 25 | $-15.7M | $-4.4M | ||
| Q2 25 | $-8.3M | $5.2M | ||
| Q1 25 | $-2.3M | $-17.4M | ||
| Q4 24 | $-19.8M | $-3.9M | ||
| Q3 24 | $-11.5M | $-2.9M | ||
| Q2 24 | $-7.7M | $-2.9M | ||
| Q1 24 | $-1.8M | $-3.3M |
| Q4 25 | 31.0% | — | ||
| Q3 25 | 50.5% | — | ||
| Q2 25 | 57.4% | — | ||
| Q1 25 | 40.6% | — | ||
| Q4 24 | 53.2% | — | ||
| Q3 24 | 56.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 16.9% | — |
| Q4 25 | -471.1% | -420.0% | ||
| Q3 25 | -834.9% | -320.8% | ||
| Q2 25 | -343.4% | -110.6% | ||
| Q1 25 | -311.7% | -333.9% | ||
| Q4 24 | -461.7% | -276.2% | ||
| Q3 24 | -378.0% | -260.9% | ||
| Q2 24 | -454.2% | -289.1% | ||
| Q1 24 | -747.8% | -196.7% |
| Q4 25 | -540.0% | -417.9% | ||
| Q3 25 | -835.8% | -316.6% | ||
| Q2 25 | -352.0% | 370.6% | ||
| Q1 25 | -91.2% | -1643.2% | ||
| Q4 24 | -626.0% | -276.4% | ||
| Q3 24 | -390.6% | -197.4% | ||
| Q2 24 | -373.1% | -229.9% | ||
| Q1 24 | -153.1% | -194.5% |
| Q4 25 | $-0.16 | $0.95 | ||
| Q3 25 | $-0.26 | $-0.04 | ||
| Q2 25 | $-0.17 | $-0.01 | ||
| Q1 25 | $-0.06 | $-1.19 | ||
| Q4 24 | $-0.52 | $-0.51 | ||
| Q3 24 | $-0.33 | $-0.37 | ||
| Q2 24 | $-0.25 | $-0.71 | ||
| Q1 24 | $-0.21 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.6M |
| Total DebtLower is stronger | $6.3M | — |
| Stockholders' EquityBook value | $4.7M | $4.0M |
| Total Assets | $32.7M | $16.3M |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | — | $9.9M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | $6.3M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | $3.2M | — |
| Q4 25 | $4.7M | $4.0M | ||
| Q3 25 | $-336.0K | $5.1M | ||
| Q2 25 | $425.0K | $3.0M | ||
| Q1 25 | $342.0K | $-23.6M | ||
| Q4 24 | $-3.0M | $-8.9M | ||
| Q3 24 | $5.5M | $-5.2M | ||
| Q2 24 | $8.5M | $-7.6M | ||
| Q1 24 | $4.2M | $-4.8M |
| Q4 25 | $32.7M | $16.3M | ||
| Q3 25 | $37.1M | $18.7M | ||
| Q2 25 | $34.6M | $10.3M | ||
| Q1 25 | $36.5M | $12.1M | ||
| Q4 24 | $37.3M | $6.6M | ||
| Q3 24 | $39.1M | $7.0M | ||
| Q2 24 | $41.3M | $11.2M | ||
| Q1 24 | $29.5M | $5.6M |
| Q4 25 | 1.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.26× | — | ||
| Q1 25 | 13.44× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $-6.3M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -459.9% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $-6.3M | ||
| Q3 25 | $-4.5M | $-2.5M | ||
| Q2 25 | $-4.1M | $-5.8M | ||
| Q1 25 | $-586.0K | $-6.2M | ||
| Q4 24 | $-930.0K | $-1.2M | ||
| Q3 24 | $-3.6M | $-3.7M | ||
| Q2 24 | $-3.1M | $-1.1M | ||
| Q1 24 | $-8.1M | $-4.5M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | $-4.6M | $-3.7M | ||
| Q2 24 | $-3.1M | $-1.2M | ||
| Q1 24 | $-9.1M | $-4.6M |
| Q4 25 | — | -459.9% | ||
| Q3 25 | — | -184.3% | ||
| Q2 25 | — | -417.6% | ||
| Q1 25 | — | -583.1% | ||
| Q4 24 | — | -86.5% | ||
| Q3 24 | -157.1% | -253.7% | ||
| Q2 24 | -151.8% | -96.2% | ||
| Q1 24 | -794.1% | -271.5% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | 34.5% | 1.0% | ||
| Q2 24 | 2.2% | 6.3% | ||
| Q1 24 | 87.3% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MOBX
| US | $1.7M | 92% |
| Other | $155.0K | 8% |
PSTV
Segment breakdown not available.
